Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More
Collaboration Between InSilicoTrials and Biofarma Group Explores the Benefits of In Silico Technology in Clinical Research
InSilicoTrials has collaborated effectively with Biofarma Group to harness the potential of in silico technology for clinical research. In this collaboration, InSilicoTrials utilized its expertise in computational modeling to analyze and reinterpret the clinical trial data of Epatrex, Biofarma Group’s … Read More
Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More
Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases
Cutting-edge EU-funded project METASTRA unites an interdisciplinary team of experts to spearhead a transformative approach to revolutionize fracture risk assessment and personalized treatment for cancer patients with vertebral metastases. A groundbreaking initiative, METASTRA is set to transform the way clinicians … Read More
Unleashing the IDPP@CLEF Potential: Assessing Predictive Algorithms and Enabling Data Sharing for Enhanced Research
Each year, the BRAINTEASER project organizes an open evaluation challenge, called iDPP@CLEF (Intelligent Disease Progression Prediction), to involve research groups from academia and industry in the assessment of the performance of their AI algorithms to predict the progression of ALS … Read More
Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling & Simulation in the Regulatory Process of Biomedical Products
In Silico Trials, the use of computational modelling & simulation in the development and regulatory assessments of biomedical products is an emerging practice in the biomedical industry. While the first technical standards, such as the ASME VV-40:2018, are appearing, there … Read More
Data science and artificial intelligence for supporting the care and cure of amyotrophic lateral sclerosis and multiple sclerosis patients: BRAINTEASER Mid Term Workshop
BRAINTEASER mid-term workshop took place on 28 February 2023 in the prestigious location of the University of Padua Botanical Garden, Italy and was attended by almost 80 participants. The organization of the event came at the end of the first phase of … Read More
FDA releases guidance for dose optimization in oncology trials
Following the 2021 launch of Project Optimus by the Oncology Center of Excellence and an extensive workshop on the topic, in January 2023 the FDA released a draft guidance for industry entitled “Optimizing the Dosage of Human Prescription Drugs and … Read More
News on our collaborations within EU Horizon 2020 projects: BRAINTEASER Mid Term Workshop
Data science and artificial intelligence for supporting the care and cure of amyotrophic lateral sclerosis and multiple sclerosis patients is the title of the BRAINTEASER Mid Term Workshop, to be held on February 28th, in the prestigious location of the … Read More
InSilicoTrials – Key player in the global in silico clinical trials market
An in silico clinical trial is also known as a virtual clinical trial. It is a method used to develop drugs and medical devices using computer simulation, powered by artificial intelligence. This method allows testing the drug samples in virtual … Read More